Back to search results

Smartshoes for Freezing of Gait in Parkinson's Disease

This study is testing special "Smartshoes with haptic vibration feedback" to see if they are safe and helpful for people with Parkinson's disease who experience freezing of gait (FoG). FoG is when your feet feel stuck to the ground, making it hard to move. We want to see if the vibrations from the shoes can help reduce these freezing episodes. You may be able to join if you are 40 to 80 years old and have Parkinson's disease, with or without FoG. We will measure how well you tolerate the shoes and how long your freezing episodes last. This study is currently unclear on its recruitment status.

Study design
This is a pilot research study planning to enroll 20 participants. It is an interventional study, meaning participants will receive a specific treatment.
What's involved
Participants will complete walking tasks on Day 1. Immediately after these tasks, you will complete a survey about how well you tolerated the device.
Compensation
Not stated in the trial record.
Follow-up
Your freezing episodes will be measured at the start of the study and again on Day 1 during walking tasks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07001072

Smartshoes for Freezing of Gait in Parkinson's Disease

Not Yet Recruiting
NAAges 40–80InterventionalTreatment
Stanford University
~20 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Smartshoes with haptic vibration feedback

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant device tolerance survey score
Measured over immediately after completion of walking tasks on day 1
+1 more outcome measured

Conditions

Parkinson Disease

Explore related trials

Parkinson Disease

NCT07001072

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Stanford University

    Palo Alto, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Hengameh Zahed, MD, PhD · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

diagnosis of PD according to the UK Brain Bank criteria
Hoehn and Yahr stages 2 to 3 during the ON phase of PD medication
Self-report episodes of FoG based on item 1 of the NFOG-Q, and score of 3 on item 2, part II
diagnosis of PD according to the UK Brain Bank criteria
Hoehn and Yahr stages 2 to 3 during the ON phase of PD medication
adult age 40-80
able to walk 10 minutes at baseline
able to provide consent
able to read and write in English at an 8th grade level.

Exclusion

moderate to severe peripheral neuropathy (based on self report or clinical exam using vibration tuning fork) which may limit ability to sense the vibratory feedback
use of orthotics incompatible with the haptic wearable shoes
severe balance deficits or daily falls at baseline
patients with dementia (MoCA\<18) who are not able to appropriately provide consent for the study
pregnant persons

What this trial measures

  • Participant device tolerance survey scoreimmediately after completion of walking tasks on day 1
  • Total duration of freezing episodesBaseline, and day 1 during each walking task (2 min per assessment)